IRON Disc Medicine, Inc.

8-K Current Report

Filed: February 27, 2026

Health Care

Pharmaceutical Preparations

Disc Medicine, Inc. (IRON) 8-K current report filed with SEC EDGAR on February 27, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.05: Costs Associated with Exit or Disposal Activities

AI Filing Analysis
8-K

Item 2.05 · Costs Associated with Exit or Disposal Activities

• FDA issued complete response letter (CRL) Feb 13 for bitopertin NDA (EPP/XLP), triggering commercial strategy pivot and layoffs
• Workforce cut ~20%, targeting commercial and supporting functions — signals company abandoning near-term commercial launch plans

+2 more insights

Other Disc Medicine, Inc. 8-K Filings

8-K Feb 26, 2026

Get deeper insights on Disc Medicine, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.